Bethesda, MD, United States of America

Yoke Peng Loh

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoke Peng Loh: Innovator in Growth Hormone Research

Introduction

Yoke Peng Loh is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of growth hormone research. With a total of 2 patents, Loh's work has the potential to impact therapeutic applications in medicine.

Latest Patents

Loh's latest patents include innovative approaches to nucleic acids encoding growth hormone. One patent focuses on a nucleic acid molecule that encodes a growth hormone (GH) with a modified RSP sorting signal. This modification allows the GH to be constitutively secreted by the nonregulated secretory pathway (NRSP) in mammalian cells. Another patent presents a modified growth hormone where amino acids within the RSP sorting signal have been mutated, enhancing its secretion capabilities.

Career Highlights

Loh is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to explore groundbreaking research in the field of growth hormones and their applications.

Collaborations

Loh has collaborated with notable colleagues, including Niamh X Cawley and Bruce J Baum. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.

Conclusion

Yoke Peng Loh's contributions to growth hormone research exemplify the importance of innovation in biotechnology. His patents reflect a commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…